EP2687110A1 - Method and device for producing regenerated tobacco material - Google Patents
Method and device for producing regenerated tobacco material Download PDFInfo
- Publication number
- EP2687110A1 EP2687110A1 EP11861287.8A EP11861287A EP2687110A1 EP 2687110 A1 EP2687110 A1 EP 2687110A1 EP 11861287 A EP11861287 A EP 11861287A EP 2687110 A1 EP2687110 A1 EP 2687110A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tobacco
- extracted liquid
- membrane
- fractionating
- fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 133
- 241000208125 Nicotiana Species 0.000 title claims abstract description 132
- 239000000463 material Substances 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims description 63
- 239000012528 membrane Substances 0.000 claims abstract description 113
- 239000007788 liquid Substances 0.000 claims abstract description 83
- 238000011282 treatment Methods 0.000 claims abstract description 56
- 238000001223 reverse osmosis Methods 0.000 claims abstract description 30
- 238000000605 extraction Methods 0.000 claims abstract description 18
- 239000002244 precipitate Substances 0.000 claims abstract description 17
- 150000004005 nitrosamines Chemical class 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 238000000108 ultra-filtration Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000011148 porous material Substances 0.000 claims description 7
- 239000008233 hard water Substances 0.000 claims description 6
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 9
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 9
- 229960002715 nicotine Drugs 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- -1 TSNAs Chemical class 0.000 description 5
- 150000002823 nitrates Chemical class 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- FLAQQSHRLBFIEZ-UHFFFAOYSA-N N-Methyl-N-nitroso-4-oxo-4-(3-pyridyl)butyl amine Chemical compound O=NN(C)CCCC(=O)C1=CC=CN=C1 FLAQQSHRLBFIEZ-UHFFFAOYSA-N 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- ZJOFAFWTOKDIFH-JTQLQIEISA-N 3-[(2s)-1-nitroso-3,6-dihydro-2h-pyridin-2-yl]pyridine Chemical compound O=NN1CC=CC[C@H]1C1=CC=CN=C1 ZJOFAFWTOKDIFH-JTQLQIEISA-N 0.000 description 1
- BXYPVKMROLGXJI-JTQLQIEISA-N 3-[(2s)-1-nitrosopiperidin-2-yl]pyridine Chemical compound O=NN1CCCC[C@H]1C1=CC=CN=C1 BXYPVKMROLGXJI-JTQLQIEISA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- XKABJYQDMJTNGQ-VIFPVBQESA-N n-nitrosonornicotine Chemical compound O=NN1CCC[C@H]1C1=CC=CN=C1 XKABJYQDMJTNGQ-VIFPVBQESA-N 0.000 description 1
- 150000002832 nitroso derivatives Chemical class 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 150000003216 pyrazines Chemical class 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000008234 soft water Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/245—Nitrosamines
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/12—Chemical features of tobacco products or tobacco substitutes of reconstituted tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
Definitions
- the tobacco extracted liquid obtained by the above extracting treatment can be stored in a storage vessel 160.
- the tobacco extracted liquid contained in the storage vessel 160 may be stored at low temperature (of 10 to 20°C) in order to prevent decomposition.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacture Of Tobacco Products (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
Description
- The present invention relates to a method of manufacturing a reconstituted tobacco material, and an apparatus used in the method.
- Various components such as nicotine, nitrates, nitrosamines, hydrocarbons and proteins are contained in tobacco materials such as the leaf, shreds, stem, stalk, and root of natural tobacco plants. These components are extracted from natural tobacco materials and are used as a smoking flavor additive to tobacco. These components include those which are desirable to be decreased in amount or to be removed (undesired components), and also include those which are desirable not to be removed or to be increased in amount (desired components), in view of the smoking flavor or some other reasons. The desired components include amino acids, sugars, nicotine, leaf surface resins, and alkaloids. The undesired components include nitrates, and nitrosamines such as tobacco-specific nitrosamines (TSNAs).
- Patent Document 1 discloses a method of manufacturing a regenerated tobacco material. The method comprises extracting a natural tobacco material to obtain an extracted solution and an extraction residue, and subjecting the extracted solution to fractionating treatment by means of ultrafiltration or reverse osmosis filtration or fractionating treatment by means of reversed-phase partition chromatography to obtain a first fraction enriched in the desired components and depleted in the undesired components and a second fraction enriched in the undesired components and depleted in the desired components. The regenerated tobacco material is manufactured by preparing a regenerated tobacco web from the extraction residue and adding the first fraction to the regenerated tobacco web.
- Patent Document 1 discloses that since the first fraction (membrane impermeable fraction) obtained by fractionating treatment by means of ultrafiltration or reverse osmosis filtration may contain nitrosamines such as TSNAs, it is desirable to subject the membrane impermeable fraction to an additional treatment so as to remove nitrosamines before the membrane impermeable fraction is added to the regenerated tobacco web.
- Patent Document 1:
USP 7677253 - An object of the present invention is to provide a method of manufacturing a reconstituted tobacco material which contains desired components of a significant amount and undesired components including TSNAs with a significantly reduced amount, by achieving practical separation of desired components and undesired components including TSNAs by means of a reverse osmosis membrane.
- In addition, an object of the present invention is to provide an apparatus for obtaining, from a tobacco extracted liquid, a fraction which contains desired components of a significant amount, and from which undesired components including TSNAs are removed by a significant amount, by means of a reverse osmosis membrane.
- According to one aspect of the present invention, there is provided a method of manufacturing a reconstituted tobacco material, comprising: (a) extracting a natural tobacco material with an extracting solvent to obtain an extraction residue and a tobacco extracted liquid containing desired components and undesired components including TSNA; (b) subjecting the tobacco extracted liquid to a fractionating treatment by means of a reverse osmosis membrane to obtain a membrane impermeable fraction containing the desired components and depleted in the undesired components and a membrane permeable fraction depleted in the desired components and enriched in the undesired components; (c) controlling the tobacco extracted liquid during the fractionating treatment to have a temperature suitable for the fractionating treatment (generally, a temperature within a range of 40 to 80°C); (d) removing precipitates, which are precipitated in the tobacco extracted liquid during the fractionating treatment, from the tobacco extracted liquid; (e) preparing a reconstituted tobacco web containing the extraction residue; and (f) adding the membrane impermeable fraction to the reconstituted tobacco web.
- According to another aspect of the present invention, there is provided a fractionating apparatus for separating desired components from TSNA-including undesired components in a tobacco extracted liquid, comprising: a process vessel which contains the tobacco extracted liquid; a fractionating device comprising a reverse osmosis membrane by which the tobacco extracted liquid is fractionated into a membrane impermeable fraction containing the desired components and depleted in the undesired components and a membrane permeable fraction depleted in the desired components and enriched in the undesired components; a pump which feeds the tobacco extracted liquid to the fractionating device under pressure; a filter for removing precipitates such as protein which are precipitated in the tobacco extracted liquid during the fractionating treatment; and a temperature controlling device which controls the tobacco extracted liquid to have a temperature suitable for the fractionating treatment during the fractionating treatment (generally, a temperature within a range of 40 to 80°C).
- According to the present invention, it is possible to manufacture a reconstituted tobacco material which contains desired components of a significant amount and undesired components including TSNAs with a significantly reduced amount, by achieving practical separation of desired components and undesired components in a tobacco extracted liquid by means of a reverse osmosis membrane.
- FIG. 1 is a schematic diagram of a fractionating apparatus according to an embodiment of the present invention.
- An aspect of the present invention relates to a method of manufacturing a reconstituted tobacco material by using a tobacco extracted liquid and an extraction residue which are obtained by extracting a natural tobacco material. On one hand, a reconstituted tobacco web containing the extraction residue is manufactured. On the other hand, the tobacco extracted liquid is subjected to fractionating treatment by means of a reverse osmosis membrane. The fractionating treatment produces a membrane impermeable fraction which contains desired components and is depleted in undesired components including TSNAs, and a membrane permeable fraction which is depleted in the desired components and enriched in the undesired components including TSNAs. A desired reconstituted tobacco material is manufactured by adding the membrane impermeable fraction to the reconstituted tobacco web. The membrane permeable fraction is discarded.
- More specifically, first, natural tobacco material is mixed with an extracting solvent, and the mixture is stirred. As the natural tobacco material, tobacco leaf, shreds, stem, stalk, and root, and a mixture thereof may be used. As the extracting solvent, water, or a mixture of water and a water-miscible organic solvent may be used. Examples of the water-miscible organic solvent include alcohols such as ethanol, and ethers such as diethyl ether. In general, the extracting treatment is carried out at a temperature of 0 to 100°C for 5 minutes to 6 hours.
- After completion of the extracting treatment, the extracted mixture obtained is subjected to separating treatment by, for example, filtration or centrifugation to separate the extracted mixture into a tobacco extracted liquid and an extraction residue.
- The natural tobacco material contains salts of metals such as potassium salt, nitrates, nicotine, sugars such as sucrose, amino acids, glycosides, amino-sugar compounds, proteins, hydrocarbons (saturated hydrocarbons, unsaturated hydrocarbons, aromatic hydrocarbons), alcohols, ethers, aldehydes, ketones, esters, lactones, quinones, acids (including acid anhydrides), phenols, amines, pyrroles, pyridines, pyrazines, alkaloids, polycyclic nitrogen-containing compounds, nitroso compounds such as nitrosamines (including TSNAs), amides, lipids, halides, sulfur-containing compounds, and inorganic elements. The tobacco extracted liquid obtained by the above extracting treatment can contain substantially all of the components mentioned above, though depending on the type of the extracting solvent used. Of these components, the desired components include amino acids, sugars, nicotine, leaf surface resins, and alkaloids, and the undesired components include nitrates and nitrosamines such as TSNAs. Typical examples of TSNAs are nitrosamines (N'-nitrosonornicotine (NNN), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), N'-nitrosoanatabine (NAT), and N'-nitrosoanabasine (NAB)). According to the present invention, nicotine and TSNAs which are similar in the chemical structures can be effectively separated from each other by a reverse osmosis membrane.
- The extraction residue is a component insoluble in the extracting solvent and consists essentially of fibers. A reconstituted tobacco web is manufactured by an ordinary method by using the extraction residue. The extraction residue may constitute the entire reconstituted tobacco web or a part of the reconstituted tobacco web. For example, a reconstituted tobacco web can be obtained by subjecting pulp material containing the extraction residue to an ordinary paper-making process.
- On the other hand, the tobacco extracted liquid is contained in a process vessel and fed to a reverse osmosis membrane under pressure. The reverse osmosis membrane fractionates the tobacco extracted liquid into a membrane permeable fraction and a membrane impermeable fraction. The membrane permeable fraction is enriched in undesired components including TSNAs. Correspondingly, the membrane impermeable fraction is depleted in the undesired components including TSNAs. In the membrane impermeable fraction, the initial amount of desired components (such as nicotine) in the tobacco extracted liquid is substantially maintained (85 wt% or more). Correspondingly, the membrane permeable fraction substantially contains no desired components.
- The reverse osmosis membrane is a membrane which is permeable to the undesired components, and substantially impermeable to the desired components. The reverse osmosis membrane is preferably impermeable to soluble components (excluding TSNAs), such as sugar, contained in the tobacco extracted liquid. A reverse osmosis membrane having a pore size of 0.1 to 3 nm may be used. The reverse osmosis membrane may be a flat sheet membrane, a membrane obtained by forming a bag-shaped membrane into a tubular shape (spiral membrane), or a hollow fiber membrane or a tubular membrane. The tobacco extracted liquid can be supplied to the reverse osmosis membrane under a pressure of, for example, 1 to 3 MPa. The membrane permeable fraction is discarded. Supply of the tobacco extracted liquid to the reverse osmosis membrane can be performed by using a high-pressure pump.
- During the fractionating treatment, the tobacco extracted liquid is sent under high pressure by the high-pressure pump, and thus the temperature of the tobacco extracted liquid rises. Therefore, in order to efficiently perform the fractionating treatment by means of the reverse osmosis membrane, the tobacco extracted liquid is controlled to fall within a temperature of generally 40 to 80°C (generally by cooling) during the fractionating treatment. Further, precipitates such as protein are precipitated in the tobacco extracted liquid because the tobacco extracted liquid reaches a relatively high temperature during the fractionating treatment, and thus the precipitates are removed. To remove the precipitates such as protein from the tobacco extracted liquid, the tobacco extracted liquid is made to pass through a filter. Since the precipitates such as protein have a diameter of 3 µm or more, a metal filter having a pore size of 3 µm or less can be used as the filter. The pore size of the filter is generally 1.8 µm or more. The precipitates, when not removed, decrease the fractionation efficiency of the reverse osmosis membrane, and makes the reverse osmosis membrane inoperative in the end. Since fine suspended matter may exist in the tobacco extracted liquid as extracted, the tobacco extracted liquid is preferably made to pass through a filter to remove the fine suspended matter in advance. The tobacco extracted liquid which is initially contained in the process vessel may have a temperature within a range of 40 to 80°C.
- In an embodiment, in order to improve the treatment efficiency, the membrane impermeable fraction can be concentrated by repeating a cycle of returning the membrane impermeable fraction to the process vessel and then subjecting the membrane impermeable fraction to the membrane fractionating treatment.
- The membrane impermeable fraction concentrated as described above is supplied with process water in the process vessel, in order to improve the fractionation efficiency by means of the reverse osmosis membrane. The membrane impermeable fraction, to which the process water has been added, is subjected to the membrane fractionating treatment, and then the obtained membrane impermeable fraction is returned to the process vessel. The cycle consisting of addition of the process water, membrane fractionating treatment, and return of the membrane impermeable fraction to the process vessel is repeated until the TSNA amount in the membrane impermeable fraction is reduced to, for example, approximately 40 wt% or less of the initial amount (TSNA removal rate is 60 wt% or more), 20 wt% or less of the initial amount (TSNA removal rate is 80 wt% or more), or 10 wt% or less of the initial amount (TSNA removal rate is 90 wt% or more). The desired components (for example, nicotine) can be maintained at 85 wt% or more of the initial amount.
- In the meantime, the process water preferably contains no bicarbonate ions. It has been found that when process water containing bicarbonate ions is used, the fractionating treatment needs more time. Thus, it is preferable to use soft water containing no bicarbonate ions as the process water. When hard water containing bicarbonate ions is used as the process water, it is preferable to remove bicarbonate ions in advance by, for example, an ultrafiltration membrane.
- The above fractionating treatment can be executed by means of a fractionating apparatus for separating desired components from TSNA-including undesired components in the tobacco extracted liquid, the fractionating apparatus comprising: a process vessel which contains the tobacco extracted liquid, a fractionating device comprising a reverse osmosis membrane by which the tobacco extracted liquid is fractionated into a membrane impermeable fraction containing the desired components and depleted in the undesired components and a membrane permeable fraction enriched in the undesired components, a pump which feeds the tobacco extracted liquid to the fractionating device under pressure, a filter for removing precipitates such as protein which are precipitated in the tobacco extracted liquid during the fractionating treatment, and a temperature controlling device which controls the tobacco extracted liquid to have a temperature suitable for the fractionating treatment (generally, a temperature within a range of 40 to 80°C) during the fractionating treatment.
- FIG. 1 is a schematic diagram illustrating a structure of the above apparatus. A
fractionating apparatus 100 illustrated in FIG. 1 comprises aprocess vessel 110 which contains the tobacco extracted liquid. Theprocess vessel 110 communicates with a high-pressure pump 130 by a line L1, and the high-pressure pump 130 communicates with afractionating device 140 comprising areverse osmosis membrane 141 by a line L2. Thefractionating device 140 communicates with theprocess vessel 110 by a line L3. Thefractionating device 140 has a discard line L4 for discarding a membrane permeable fraction. The line L1 is provided with afilter 120 for removing precipitates such as protein which are precipitated in the tobacco extracted liquid, wherein the precipitates are increased by repeated fractionating treatments of the tobacco extracted liquid by means of thefractionating device 140. As described above, thefilter 120 has pores of 3 µm in order to prevent precipitates such as protein precipitated in the tobacco extracted liquid from passing through thefilter 120. The line L3 is provided with aheat exchanger 150 serving as a temperature controlling device which controls and maintains a temperature of the tobacco extracted liquid within a range of 40 to 80°C, wherein the temperature of the tobacco extracted liquid rises during the repeated fractionating treatments. For example, theheat exchanger 150 can be a device which introduces cooling water into a part around the line L3 from a line L5, and discharges the water after heat exchange from a line L6. - The tobacco extracted liquid obtained by the above extracting treatment can be stored in a
storage vessel 160. The tobacco extracted liquid contained in thestorage vessel 160 may be stored at low temperature (of 10 to 20°C) in order to prevent decomposition. - One batch of tobacco extracted liquid TEL is supplied to the
process vessel 110 from thestorage vessel 160 through a line L7. Then, the tobacco extracted liquid contained in theprocess vessel 110 is fed from theprocess vessel 110 to thefractionating device 140 through thefilter 120 by drive of the high-pressure pump 130. In thefractionating device 140, the tobacco extracted liquid is fractionated into a membrane permeable fraction which is depleted in the desired components and enriched in the undesired components including TSNAs, and a membrane impermeable fraction which is depleted in the undesired components including TSNAs and containing the desired components, by means of thereverse osmosis membrane 141 of thefractionating device 140. The membrane permeable fraction is discarded from thefractionating device 140 through the line L4. - The membrane impermeable fraction is returned to the
process vessel 110 through the line L3. The membrane impermeable fraction which has been returned to theprocess vessel 110 is supplied again to thefractionating device 150 by the high-pressure pump 130 through the lines L1 and L2, and fractionated into a membrane permeable fraction and a membrane impermeable fraction. The membrane impermeable fraction can be returned to theprocess vessel 110 through the line L3. Needless to say, the membrane permeable fraction is discarded each time through the line L4. - When the membrane impermeable fraction is concentrated by repeated fractionating treatments as described above, process water is added from a
water vessel 170 to the membrane impermeable fraction contained in theprocess vessel 110 through a line L8, in order to prevent decrease in efficiency of the fractionating treatment by means of the reverse osmosis membrane. The line L8 may be provided with anultrafiltration device 180 comprising anultrafiltration membrane 181, in order to remove bicarbonate ions in the case where the water is hard water containing bicarbonate ions. A filtrate (bicarbonate ion-removed water) derived from theultrafiltration device 180 is added as the process water to theprocess vessel 110 through the line L8. The membrane impermeable fraction to which the process water has been added is repeatedly subjected to the fractionating treatment until the amount of TSNAs in the fraction is reduced to, for example, approximately 40 wt% or less, 20 wt% or less, or 10 wt% or less, of the initial amount thereof. The amount (volume) of the membrane permeate obtained by fractionating the membrane impermeable fraction containing the process water is the same as the amount (volume) of the added process water. During the concentration and the repeated cycle of water addition and fractionating treatment, the tobacco extracted liquid (the concentrated tobacco extracted liquid and the tobacco extracted liquid containing the process water) is cooled to a temperature of 40 to 80°C by theheat exchanger 150, and maintained at the temperature, and precipitates such as protein are removed from the tobacco extracted liquid by thefilter 120. The amount of the undesired components, such as TSNAs, in the membrane impermeable fraction can be determined by measuring the amount of the desired components or the undesired components contained in the membrane permeable fraction discharged from the line L4. The temperature of the tobacco extracted liquid can be monitored by atemperature sensor 180, which is provided on the line L2 and close to thefractionating device 141. - In the above embodiment, although the
filter 120 is provided (on the line L1) between theprocess vessel 110 and the high-pressure pump 130, a similar filter 120' may be provided on the line L3 between thefractionating device 140 and theheat exchanger 150, and/or asimilar filter 120 may be provided on the line L3 between theheat exchanger 150 and theprocess vessel 110, instead of or in addition to thefilter 120, as indicated by broken lines in FIG. 1. In addition, as indicated by broken lines in FIG. 1, theprocess vessel 110 may be externally provided with a line L9 to circulate the tobacco extracted liquid contained in theprocess vessel 110, and the line L9 may be provided with asimilar filter 120"'. To provide a filter (on the line L2) between the high-pressure pump 110 and thefractionating device 140, however, is not preferable, because precipitates such as protein which have been captured by the filter, undesirably pass through the pores of the filter by the tobacco extracted liquid which is pumped under high pressure by the high-pressure pump 130 and have adverse influence on the fractionating treatment. - The present invention will be explained hereinafter by examples, but the present invention is not limited by them.
- In the present Example, fractionating treatment was performed by using the apparatus illustrated in FIG. 1. Duratherm Excel R0 4040HR manufactured by GE Water Technologies was used as the reverse osmosis membrane.
- First, 10 kg of tobacco scraps consisting of a mixture of tobacco leaf scraps (mixture of flue-cured type and Burley type) and stem scraps was mixed with 50 L of water at a temperature of 60°C, and stirred to perform extraction of tobacco shreds. The extracted mixture obtained was filtered to be separated into tobacco extracted liquid and extraction residue. The concentration of TSNAs (sum of NNN, NNK, NAT, and NAB) in the tobacco extracted liquid was measured by chromatography. The concentration was 424 mg/m3.
- The extraction residue was subjected to paper-making process, and thereby a reconstituted tobacco web was obtained. On the other hand, the tobacco extracted liquid was stored in the
storage vessel 160. - Next, 33.5 L of tobacco extracted liquid was introduced into the
process vessel 110 from thestorage vessel 160. By driving the high-pressure pump 130 (which feeds the tobacco extracted liquid under a pressure of 2 MPa), the tobacco extracted liquid was supplied to thereverse osmosis membrane 141 through the filter 120 (stainless steel filter having a pore size of 3 µm). A membrane impermeable fraction was returned to theprocess vessel 110. The membrane impermeable fraction which has been returned to theprocess vessel 110 was repeatedly subjected to the above fractionation cycle, until the amount of the membrane impermeable fraction was reduced to 18 L. - 1L of water (process water), from which bicarbonate ions have been removed in advance by means of the
ultrafiltration membrane 181, was added to the 18L of concentrated membrane impermeable fraction in theprocess vessel 110, and membrane fractionating treatment was performed in a similar manner. The membrane impermeable fraction was returned to theprocess vessel 110, 1L of water, from which bicarbonate ions have been removed in advance, was added to the membrane impermeable fraction again, and the membrane impermeable fraction was returned to theprocess vessel 110. Addition of the process water and fractionating treatment were repeated until the total amount of the added process water reached 133 L, and thereby a desired (final) membrane impermeable fraction was obtained (it took approximately one hour since concentration was started). During the fractionating treatments, the tobacco extracted liquid was maintained at approximately 60°C, and precipitates such as protein were removed by thefilter 120. The amount of TSNAs in the obtained membrane impermeable fraction was 4.5% of the initial amount thereof (removal rate of 95.5%), and nicotine was maintained at approximately 86.6% of the initial amount thereof. The membrane impermeable fraction obtained as described above was added to the reconstituted tobacco web, and thereby a reconstituted tobacco material was obtained. - Example 2 was performed in the same procedure as Example 1, except that hard water, from which bicarbonate ions were not removed, was used without any treatment as the process water. In the present case, 133 L of hard water in total was added in order to obtain a final membrane impermeable fraction having the same TSNA removal rate and nicotine maintenance rate as those of Example 1. Approximately 80 minutes was required to obtain the final membrane impermeable fraction since concentration was started.
Claims (10)
- A method of manufacturing a reconstituted tobacco material, comprising:(a) extracting a natural tobacco material with an extracting solvent to obtain an extraction residue and a tobacco extracted liquid containing desired components and undesired components including tobacco-specific nitrosamines;(b) subjecting the tobacco extracted liquid to a fractionating treatment by means of a reverse osmosis membrane to obtain a membrane impermeable fraction containing the desired components and depleted in the undesired components and a membrane permeable fraction depleted in the desired components and enriched in the undesired components;(c) controlling the tobacco extracted liquid during the fractionating treatment to have a temperature suitable for the fractionating treatment;(d) removing precipitates, which are precipitated in the tobacco extracted liquid during the fractionating treatment, from the tobacco extracted liquid;(e) preparing a reconstituted tobacco web containing the extraction residue; and(f) adding the membrane impermeable fraction to the reconstituted tobacco web.
- The method according to Claim 1, wherein the tobacco extracted liquid is controlled to have a temperature within a range of 40 to 80°C in the step (c).
- The method according to Claim 1 or 2, wherein the step (b) comprises:repeatedly performing the fractionating treatment to obtain a concentrated membrane impermeable fraction, andrepeating a cycle of consisting of addition of process water to the concentrated membrane impermeable fraction and the fractionating treatment of the membrane impermeable fraction supplied with the process water.
- The method according to Claim 3, wherein the cycle is repeated until a membrane impermeable fraction, from which the tobacco-specific nitrosamines contained in the tobacco extracted liquid obtained in the step (a) is removed by 60 wt% or more of its initial amount, is obtained.
- The method according to any one of Claims 1 to 4, wherein the step (c) is performed by using a filter having a pore size of 3 µm or less.
- The method according to any one of Claims 3 to 5, wherein the process water is obtained by removing bicarbonate ions from hard water containing bicarbonate ions.
- A fractionating apparatus for separating desired components from tobacco-specific nitrosamine-including undesired components in a tobacco extracted liquid, comprising:a process vessel which contains the tobacco extracted liquid;a fractionating device comprising a reverse osmosis membrane by which the tobacco extracted liquid is fractionated into a membrane impermeable fraction containing the desired components and depleted in the undesired components and a membrane permeable fraction depleted in the desired components and enriched in the undesired components;a pump which feeds the tobacco extracted liquid to the fractionating device under pressure;a filter for removing precipitates such as protein which are precipitated in the tobacco extracted liquid during the fractionating treatment; anda temperature controlling device which controls the tobacco extracted liquid to have a temperature suitable for the fractionating treatment during the fractionating treatment.
- The apparatus according to Claim 7, wherein the temperature controlling device controls the tobacco extracted liquid to have a temperature within a range of 40 to 80°C.
- The apparatus according to Claim 7 or 8, wherein the temperature controlling device is constituted of a heat exchanger.
- The apparatus according to any one of Claims 7 to 9, further comprising:an ultrafiltration device which comprises ultrafiltration membrane for removing bicarbonate ions. from hard water containing bicarbonate ions, and is configured to provide bicarbonate ion-removed water as process water.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2011/056077 WO2012124059A1 (en) | 2011-03-15 | 2011-03-15 | Method and device for producing regenerated tobacco material |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2687110A1 true EP2687110A1 (en) | 2014-01-22 |
EP2687110A4 EP2687110A4 (en) | 2014-11-12 |
EP2687110B1 EP2687110B1 (en) | 2017-12-13 |
Family
ID=46830190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11861287.8A Active EP2687110B1 (en) | 2011-03-15 | 2011-03-15 | Method and device for producing regenerated tobacco material |
Country Status (4)
Country | Link |
---|---|
US (1) | US20140014123A1 (en) |
EP (1) | EP2687110B1 (en) |
RU (1) | RU2562037C2 (en) |
WO (1) | WO2012124059A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103919272A (en) * | 2014-04-25 | 2014-07-16 | 安徽中烟再造烟叶科技有限责任公司 | Cryo-concentration system and method for reconstituted tobacco extraction liquid |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2645577C2 (en) * | 2013-03-15 | 2018-02-21 | Филип Моррис Продактс С.А | Methods of decreasing quantity of one or multiple tobacco-specific nitrosamines in tobacco material |
CN103284314B (en) * | 2013-04-16 | 2015-09-30 | 川渝中烟工业有限责任公司 | Cylinder drum tubular plate type cut tobacco dryer is adopted to reduce the baking silk method of cigarette NAT burst size |
CN103284305B (en) * | 2013-04-16 | 2015-09-30 | 川渝中烟工业有限责任公司 | Cylinder drum tubular plate type cut tobacco dryer is adopted to reduce the baking silk method of cigarette NNN burst size |
CN103284293B (en) * | 2013-04-16 | 2015-06-10 | 川渝中烟工业有限责任公司 | Cut tobacco drying technology method adopting SH94 to reduce H value of cigarettes |
CN104138028B (en) * | 2014-07-15 | 2016-02-24 | 上海烟草集团有限责任公司 | A kind of extracting method of tobacco flavor composition and application thereof |
WO2018211119A1 (en) * | 2017-05-19 | 2018-11-22 | Philip Morris Products S.A. | Method for casting an alkaloid containing material |
CN108056494A (en) * | 2018-01-31 | 2018-05-22 | 湖北中烟工业有限责任公司 | A kind of system and method for improving recombination tobacco leaf and wrapping up in clothing coating fluid degree of purity |
CN110314548A (en) * | 2019-07-17 | 2019-10-11 | 安徽科博瑞环境科技有限公司 | Reconstituted tobacco extracts liquid film separation purification concentration systems and its treatment process |
CN113218700B (en) * | 2021-04-29 | 2022-04-15 | 河海大学 | Membrane collection device and method for plant root exudates in soil culture mode |
CN115251454A (en) * | 2022-05-20 | 2022-11-01 | 深圳麦克韦尔科技有限公司 | Method for treating tobacco extract, aerosol-generating substrate and atomizer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58126775A (en) * | 1981-09-14 | 1983-07-28 | リ−フ・プロテインズ・インコ−ポレ−テツド | Production of tobacco from which nicotine, green color and protein are removed in order to be used as smoking product |
EP1623634A1 (en) * | 2003-05-06 | 2006-02-08 | Japan Tobacco Inc. | Process for producing regenerated tobacco material |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1016844A (en) * | 1911-06-29 | 1912-02-06 | Adolph Moonelis | Artificial tobacco and process of making same. |
US4131117A (en) * | 1976-12-21 | 1978-12-26 | Philip Morris Incorporated | Method for removal of potassium nitrate from tobacco extracts |
US5005593A (en) * | 1988-01-27 | 1991-04-09 | R. J. Reynolds Tobacco Company | Process for providing tobacco extracts |
JP2505861B2 (en) * | 1988-07-06 | 1996-06-12 | 株式会社テック | Dot printer |
CN100334979C (en) * | 2002-07-18 | 2007-09-05 | 法塞克斯公司 | Reduction of constituents in tobacco |
EP2138214A1 (en) * | 2008-06-27 | 2009-12-30 | British American Tobacco (Investments) Limited | A method for removing polycyclic aromatic hydrocarbons |
JP2010042368A (en) * | 2008-08-14 | 2010-02-25 | Fujifilm Finechemicals Co Ltd | Method and apparatus for solid-liquid separation |
-
2011
- 2011-03-15 EP EP11861287.8A patent/EP2687110B1/en active Active
- 2011-03-15 RU RU2013145864/12A patent/RU2562037C2/en active
- 2011-03-15 WO PCT/JP2011/056077 patent/WO2012124059A1/en unknown
-
2013
- 2013-09-12 US US14/025,550 patent/US20140014123A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58126775A (en) * | 1981-09-14 | 1983-07-28 | リ−フ・プロテインズ・インコ−ポレ−テツド | Production of tobacco from which nicotine, green color and protein are removed in order to be used as smoking product |
EP1623634A1 (en) * | 2003-05-06 | 2006-02-08 | Japan Tobacco Inc. | Process for producing regenerated tobacco material |
Non-Patent Citations (1)
Title |
---|
See also references of WO2012124059A1 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103919272A (en) * | 2014-04-25 | 2014-07-16 | 安徽中烟再造烟叶科技有限责任公司 | Cryo-concentration system and method for reconstituted tobacco extraction liquid |
Also Published As
Publication number | Publication date |
---|---|
RU2562037C2 (en) | 2015-09-10 |
EP2687110B1 (en) | 2017-12-13 |
US20140014123A1 (en) | 2014-01-16 |
EP2687110A4 (en) | 2014-11-12 |
RU2013145864A (en) | 2015-04-27 |
WO2012124059A1 (en) | 2012-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2687110B1 (en) | Method and device for producing regenerated tobacco material | |
US7677253B2 (en) | Method of manufacturing regenerated tobacco material | |
JP6994069B2 (en) | Protein-enriched tobacco-derived composition | |
JP4408289B2 (en) | Method for producing recycled tobacco material | |
CN104351943B (en) | A kind of method utilizing electroosmose process to reduce TSNA and nitrate content in reproduced tobacco concentrated liquid | |
JP4821024B2 (en) | Reduction of components in tobacco | |
EP2879527B1 (en) | Tobacco extract, preparation thereof | |
CN104270968B (en) | Liquid tobacco compositions and manufacturing method thereof | |
HUT66688A (en) | Process for treating of tobacco in particular for change of character of tobacco material | |
CN110662436A (en) | Method for producing tobacco extract | |
EP3287015A1 (en) | Method for manufacturing sheet tobacco | |
AU2013349411B2 (en) | Treatment of tobacco material | |
WO2012132007A1 (en) | Process and apparatus for producing regenerated tobacco material | |
KR100583891B1 (en) | Method of highly Extracting Megastigmatrienones from tobacco, and Tobacco flavoring stuff with the extract | |
WO2014080225A1 (en) | Treatment of tobacco material | |
CN110621169A (en) | Method for producing tobacco extract | |
TH21003B (en) | Method for producing reconstituted tobacco sheets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130829 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20141013 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A24B 15/24 20060101AFI20141007BHEP |
|
17Q | First examination report despatched |
Effective date: 20160204 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602011044260 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A24B0015240000 Ipc: A24B0015120000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A24B 15/12 20060101AFI20170627BHEP |
|
INTG | Intention to grant announced |
Effective date: 20170714 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 953519 Country of ref document: AT Kind code of ref document: T Effective date: 20171215 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602011044260 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
GRAM | Information related to correction after decision after decision to grant or to maintain patent in amended form deleted |
Free format text: ORIGINAL CODE: EPIDOSDCDEC |
|
GRAT | Correction requested after decision to grant or after decision to maintain patent in amended form |
Free format text: ORIGINAL CODE: EPIDOSNCDEC |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180313 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 953519 Country of ref document: AT Kind code of ref document: T Effective date: 20171213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180314 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180313 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180413 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602011044260 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602011044260 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
26N | No opposition filed |
Effective date: 20180914 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20180315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20180331 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180315 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181002 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180331 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180331 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180315 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20110315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171213 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20220321 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20221222 Year of fee payment: 13 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230530 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20230401 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230401 |